Abstract
Proctitis is the principle dose-limiting toxicity of radiation therapy for localized prostate cancer. SBRT could minimize rectal toxicity by reducing the volume of rectum receiving high radiation therapy doses and offers the potential radiobiologic benefits of hypofractionation. This study sought to evaluate the incidence and severity of proctitis following stereotactic body radiation therapy (SBRT) for prostate cancer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology, Biology, Physics
Paper Title
Journal
Date
